Public Offering

CAMBRIDGE, Mass., August 18, 2026 Amylyx Pharmaceuticals has announced the commencement of an underwritten public offering of $350.0 million...

SAN DIEGO, June 19, 2026 Fapon Biopharma and MOTE Therapeutics have announced plans to present their innovative dual-targeting, dual-platform...

BOSTON and ROLLE, Switzerland, June 19, 2026 SOPHiA GENETICS, a global leader in AI-driven precision medicine, has announced the...

SAN FRANCISCO & BOSTON, USA | March 24, 2026 Apogee Therapeutics, Inc. has successfully announced the pricing of its...

New York, United States & Waltham, Massachusetts – March 9, 2026 Dianthus Therapeutics, Inc., a clinical-stage biotechnology company focused...

SAN FRANCISCO, Feb. 13, 2026 — Nektar Therapeutics announced the successful closing of a $460 million underwritten public offering,...

Minneapolis, U.S., and Brisbane, Australia, January 21, 2026 — Anteris Technologies Global Corp. announced the pricing of a $200...

BOSTON, December 12, 2025 — Contineum Therapeutics, Inc. announced the pricing of an upsized $90.0 million public offering of...

Miami, Florida, November 28, 2025 Pasithea Therapeutics has announced the pricing of a $60 million public offering ,strengthening its...

Dateline — WALTHAM, Mass. and BOULDER, Colo., November 11, 2025:Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company developing precision...